依达拉奉治疗ICU急性缺血缺氧性脑病的效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the effect of Edaravone on ICU acute ischemic hypoxic encephalopathy.Methods A total of 52 patients with acute ischemic hypoxic encephalopathy from January 2017 to January 2019 in our hospital′s ICU for treatment were selected as the research objects,and were divided into control group (n=26)and observation group(n=26)according to the random drawing method.The control group was treated mechanical assisted ventilation to improve the cerebral circulation and maintain the vital signs of the patients.The observation group was treated with Edaravone based on the treatment in the control group.After two courses of treatment,the treatment effect,neurological deficit scores before and after treatment and the occurrence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group (92.3%)was higher than that in the control group (73.1%),the difference was statistically significant(P＜0.05);before treatment and on the 7th day after treatment,the neurological deficits scores of patients in the two groups,the differences were not statistically significant(P＞0.05).On the 14th and 28th days after treatment,the neurological deficit scores of the two groups of patients were lower than those of the group before treatment,and the neurological deficit scores of the observation group were lower than those of the control group on the 14th and 28th days after treatment,the differences were statistically significant(P＜0.05).The total incidence of adverse reactions in the observation group was lower than that in the control group,and the difference was statistically significant(P＜0.05).Conclusion The use of Edaravone in the treatment of acute ischemic hypoxic encephalopathy in ICU has a good effect,can improve patients′neurological deficits and reduce the occurrence of adverse reactions,and has high clinical application value.

Received: 25 December 2019

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Man-ni

Cite this article:

CHEN Man-ni. Edaravone;ICU;Acute ischemic hypoxic encephalopathy;Treatment effect;Adverse reactions[J]. 中国当代医药, 2020, 27(24): 99-101.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2020/V27/I24/99

[1]	樊华.神经节苷酯治疗新生儿缺血缺氧性脑病的疗效及对其神经功能的影响[J].临床医学研究与实践，2017，2（16）：42-43.
[2]	宋礼坡，王春梅，褚燕琦，等.急性缺血性脑卒中患者依达拉奉治疗相关肝损伤临床分析[J].药物不良反应杂志，2018，20（3）：164-168.
[3]	中华神经学会，中华神经外科学会.脑卒中患者临床神经功能缺损程度评分标准（1995）[J].中华神经外科杂志，1996，29（6）：381-382.
[4]	张磊，刘建民.美国国立卫生研究院卒中量表[J].中华神经外科杂志，2012，28（5）：455.
[5]	关旭，刘军.丹红注射液联合依达拉奉对急性缺血性脑卒中患者血管内皮功能、血液流变学影响及疗效观察[J].国际医药卫生导报，2017，27（2）：236-239.
[6]	张海军.依达拉奉联合丁苯酞治疗缺血性脑卒中的疗效研究[J].中国合理用药探索，2017，14（7）：20-22.
[7]	于沛霞，薄立军，薛辉，等.依达拉奉对脑缺血缺氧新生大鼠神经功能的影响[J].河北医科大学学报，2017，38（4）：423-427.
[8]	詹兰兰.醒脑静联合依达拉奉对缺血性脑卒中患者血清EPO及MMP-9水平的影响[J].山西职工医学院学报，2019，29（3）：44-46.
[9]	章鹏.早期依达拉奉联合CT灌注成像指导溶栓对梗死时间不明性脑梗死患者神经功能缺损的影响[J].医学临床研究，2018，35（7）：1380-1382.
[10]	李晓鹃，胡鹏，余强，等.PCI术联合依达拉奉治疗ST段抬高型急性心肌梗死的疗效及其机制研究[J].疑难病杂志，2018，45（8）：757-761.
[11]	王凌啸，郑锡铭.缺血缺氧性脑病新生儿血清IL-1β、IL-6和TNF-α水平变化及其临床意义[J].中国实用医刊，2017，44（2）：72-74.
[12]	高忆墨.护理干预对新生儿缺血缺氧性脑病（HIE）临床效果的影响[J].国际护理学杂志，2017，36（9）：1213-1216.
[13]	米艳，高小平，朱清风，等.依达拉奉对大鼠脑缺血再灌注损伤的机制研究[J].中国医药导报，2019，16（13）：16-19.
[14]	贾蕾，王娟娟.急性缺血性脑卒中采取依达拉奉联合丁苯酞治疗的效果和安全性探讨[J].临床医学研究与实践，2017，2（26）：14-15.
[15]	张巍.丹红注射液联合依达拉奉治疗急性缺血性脑卒中的临床研究[J].中国基层医药，2017，24（7）：1050-1053.